Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fox Corp Class A (FOXA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Fox Corp Class ATrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Fox Corp Class A vs Vir Biotechnology Inc. Common Stock — how do they compare? Fox Corp Class A trades at $62.63 (market cap $24.93B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Fox Corp Class A is far larger — about 13.8× Vir Biotechnology Inc. Common Stock's market cap, and Fox Corp Class A pays a 0.93% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class A for 35 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

FOXAVIR
Market Cap
$24.93B$1.80B
Volume
2,221,9531,782,836
Sector
MediaHealth
52-Week High
$76.11$11.78
52-Week Low
$48.79$5.12
Typical Hold Time
35 Days0 Days
Enterprise Value
$28.30B$1.36B
Dividend Yield
0.93%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fox Corp Class A

Fox Corporation (FOXA) trades at $62.50, down slightly by 0.14% with a bearish technical signal. The company shows strong fundamentals with revenue growth from $14.0B in 2024 to $16.3B in 2025 and consistent earnings beats. Analyst consensus is bullish with a $72.00 price target, though the pending $22B Roku acquisition faces DOJ scrutiny. Cash flow improved significantly to $1.03B net in 2025, while 2026 projections show potential pressure.

FOXA presents a compelling value opportunity with reasonable valuations (P/E 16.3) and strong profitability (ROE 14.29%). The Roku deal represents both growth potential and regulatory risk. With zero sell ratings and insider buying, institutional sentiment remains positive despite technical weakness. Key risks include integration challenges and advertising market volatility.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FOXA

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Fox Corp Class A

Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.

Read more on FOXA →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →